Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.53) by 32.08 percent. This is a 94.39 percent increase over losses of $(12.48) per share from the same period last year. The company reported quarterly sales of $872.29 thousand which missed the analyst consensus estimate of $1.75 million by 50.16 percent. This is a 9.57 percent increase over sales of $796.09 thousand the same period last year.